S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CHRS Coherus BioSciences Inc

1.83

-0.05 (-2.66%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Coherus BioSciences Charts.

Coherus BioSciences Inc News

Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
Thursday 30 May 2024 (2 days ago) • GlobeNewswire Inc.

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Friday 24 May 2024 (1 week ago) • GlobeNewswire Inc.

Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
Thursday 23 May 2024 (1 week ago) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Wednesday 22 May 2024 (1 week ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 14 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
Friday 10 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 9 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
Thursday 9 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer
Wednesday 8 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
Thursday 2 May 2024 (1 month ago) • GlobeNewswire Inc.

More Coherus BioSciences Inc News Articles

UMA Voting Token v1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions